Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial
Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.

Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and a funding-status notice along with Revision: v3.4.1 were removed. These changes are cosmetic and do not affect study details or user actions on the page.SummaryDifference0.2%

- Check21 days agoChange DetectedA Notice about a lapse in government funding and NIH Clinical Center status was added, with links to cc.nih.gov and opm.gov for updates. The site revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedPage UI updates add Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, and remove Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now shows an 'Last Update Posted (Estimated)' label and updated date fields (including 2025-12 and 2029-12), with some previous timestamp entries removed; this affects how update recency is displayed but not the substantive study information.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now lists study locations across multiple US states and international sites, and shows Revision: v3.3.3. This update informs where to enroll and whom to contact at each site.SummaryDifference1%

Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.